Abeona Therapeutics Inc. Stock
Price
Target price
€6.70
€6.70
-4.130%
-0.28
-4.130%
€21.05
28.03.24 / Tradegate
WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Abeona Therapeutics Inc. Stock
Heavy losses for Abeona Therapeutics Inc. today as the stock fell by -€0.280 (-4.130%).
Currently there is a rather positive sentiment for Abeona Therapeutics Inc. with 3 Buy predictions and 1 Sell predictions.
With a target price of 21 € there is potential for a 213.43% increase which would mean more than doubling the current price of 6.7 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. | -4.130% | -2.687% | -1.034% | 159.690% | 42.251% | -82.386% | - |
Salarius Pharmaceuticals Inc. | 1.470% | -18.824% | -22.617% | -76.389% | -25.405% | -98.665% | -99.992% |
Ardelyx Inc. | -1.160% | -6.371% | -22.654% | 73.980% | 16.955% | 25.791% | - |
Evolus Inc | -0.770% | 2.362% | -2.985% | 66.667% | 39.037% | 31.287% | - |
Comments
Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat